Monthly Archives: March 2023

Top 10 Biopharmaceutical R&D Budgets in 2022

      Btobioinnovation.com  Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com     SPECIAL REPORT T Top 10 Biopharmaceutical R&D Budgets in 2022     Every year Fierce Biotech discloses the ranking of the R&D spending of the top ten biopharmaceutical companies in the world. The cumulative R&D spending of these companies is now close […]

read more

Down Syndrome and Alzheimer’s Disease.

      Btobioinnovation.com  Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com     SPECIAL REPORT: International Down Syndrome Day.   Down Syndrome and Alzheimer’s Disease.     Many scientists are not aware of the strong link existing between Down syndrome and Alzheimer’s disease. Down syndrome, also known as Trisomy 21, is a genetic defect caused […]

read more

The Alzheimer’s puzzle isn’t yet solved.

    Btobioinnovation.com  Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com         Commentary     The Alzheimer’s puzzle isn’t yet solved.     The approval of Aduhelm (aducanumab) in June 2021, the positive results disclosed for donanemab in November 2022 and the accelerated approval of Leqembi (lecanemab) in January 2023, three drugs which […]

read more

Alzheimer’s Disease Conundrum

      Btobioinnovation.com  Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com       The following article and its associated commentary were published in the February 2023 edition of MedNous. We are grateful to Victoria English, MedNous Editor, for her comments, improvements and the final edition of this publication.   Alzheimer’s Disease Conundrum   Two […]

read more